Schlieren, Switzerland
Polaroid Therapeutics Announces Strategic Hire: Markus Rothmaier Takes Helm of Research and Development
Polaroid Therapeutics, a Swiss-based biotech start-up, today announces the appointment of Markus Rothmaier as its inaugural Head of Research and Development (R&D). With over two decades of pharmaceutical R&D leadership experience, Rothmaier will drive product development, strategic partnerships and propel Polaroid Therapeutics' revolutionary anti-microbial technologies forward.